Focus

Consulting

• Physiogenix • Illingworth Research Group • Skanderbeg Capital • CannDelta • Hayden IR • Psilocybrand • Allay Consulting • Society for Psychedelic Outreach Reform and Education (SPORE) • OmTerra
• Associate Consultant

Cultivator

• Myco Systemics • Midwest Grow Kits • Quality Spores • North Spore • Cyber-Shrooms • Magic Mushrooms Shop • Shroom Supply • Wholecelium • Avalon Magic Plants • Gorilla Mushroom Kits • Truffle Magic • Elephants • Dutch Growkits • Per Grow • Mushbox • Zativo • Canadian Psilocybin Collective • Smallhold • Back of the Yards Algae Sciences • Headland • Optimi Health • Psyence • Levitee Labs • ShroomBloom • Entheogenesis Australis • Albert Labs

Data

• Fraqtal • Psychedelic Survey • Aurelius Data • Blossom • Maya • Psychedelic Invest • Psychedelic Support • Quantified Citizen • Report on Psychedelics • Tune In Psychedelics • PsyIndex • Introspect • Opportune • Total Brain • Viridia Life Science • Neuly • Prohibition Partners • Mindstrong • PatientSafe Solutions • Speak Ai • Apollo Neuro • Sana Health • Pharmather • ilumivu • Reconscious Medical • Puff Digital • MyDelica • Emyria • Mindseye • Apotheca • Enter Here • Heally • Psynautics • Albert Labs • Cognistx • Psychable • Cydelic • Nue Life
• Clinical Data Manager

Development

• Green Light Medicines • Diamond Therapeutics • MAPS Public Benefit Corporation • Center for the Neuroscience of Psychedelics • Awakn Life Sciences, Inc. • Canada Research Chemicals • Beckley Psytech • MagicMed Industries • IntelGenx • Tryp Therapeutics • CLOV Biopharma Corp • Lundbeck • Mimosa Therapeutics • Magical Brands • M2BIO • Psilera Biosciences • Bionomics • Physiogenix • BioPharm • Dalriada • Jaguar Health • Pharmather • Noetic Foundry • Empath Bio • Pilz BioScience • Allied Corp • Journey Colab • Mera Life Sciences • Olson Lab • XPhyto • ProPharma Group • Optimi Health • AIkido Pharma • Psyence • HealthTech Connex • Terran Biosciences • Nirvana Life Sciences • Algernon Pharmaceuticals • Conscious Mind • Ninnion • AMRI • GoodCap • Terasaki Institute • Syreon Research Institute • MYND Life Sciences Inc. • The Psynergia Alliance • GH Research • Lattice Biologics • Halucenex • CURE Pharmaceutical • Psy Therapeutics • PsiloTec • Wesana Health • Reset Pharma • Cannabics Pharmaceuticals • Mycrodose Therapeutics • Cubed3 Biotech • Clarify Pharma PLC • Wonder Sciences • Lennham Pharmaceuticals • PharmAla Biotech • MAPS • Woven Science • BetterLife Pharma Inc. • HMNC Brain Health • Aphrodite Health • Ketamine One • Goodness Growth • Clearmind • Eastra Health • Kaiyon Biotech • Psylo • MindBio Therapeutics • Noonautics • Mycologics • Filament Health • Neosinus • Apex Labs • Arma Therapeutics

DMT

• CB Therapeutics • Entheon • Alien Insect • Psilohuasca • CaaMTech • Viridia Life Science • DMTx • Legit Research Chemical Vendors USA • XPhyto • Algernon Pharmaceuticals • GH Research • The Sentinel • Mr. Psychedelic Law • Limina Foundation • Society for Psychedelic Outreach Reform and Education (SPORE) • Small Pharma • Psilera Biosciences • MagicMed Industries • Mindset Pharma • atai Life Sciences
• Human psychopharmacology of N, N-dimethyltryptamine • The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator • N, N-dimethyltryptamine: an endogenous hallucinogen • A dimethyltryptamine-forming enzyme in human blood • The psychedelic model of schizophrenia: the case of N, N-dimethyltryptamine • Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids • Dose-response study of N, N-dimethyltryptamine in humans: I. Neuroendocrine, autonomic, and cardiovascular effects • Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine • Dose-response study of N, N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale • Effects of 5-methoxy-N, N-dimethyltryptamine on central monoamine neurons • Hydroxylation and N-demethylation of N, N-dimethyltryptamine • Behavioral effects of 5-methoxy-N: N-dimethyltryptamine, other tryptamines, and LSD • A Fatal Intoxication Following the Ingestion of 5-Methoxy-N,N-Dimethyltryptamine in an Ayahuasca Preparation • When the endogenous hallucinogenic trace amine N, N-dimethyltryptamine meets the sigma-1 receptor • Quantitation of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Plasma after Oral Dosing with Ayahuasca • Dimethyltryptamine experiments with psychotics • Agonist properties of N, N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors • Neuropharmacology of N, N-dimethyltryptamine • DISCARNATE ENTITIES AND DIMETHYLTRYPTAMINE (DMT): PSYCHOPHARMACOLOGY, PHENOMENOLOGY AND ONTOLOGY. • Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies • Differential tolerance to biological and subjective effects of four closely spaced doses of N, N-dimethyltryptamine in humans • Metabolism of the hallucinogen N, N-dimethyltryptamine in rat brain homogenates • In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N, N-dimethyltryptamine in the rat • Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N, N-dimethyltryptamine in the rat • Psychedelic 5-methoxy-N, N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions • Dimethyltryptamine levels in blood of schizophrenic patients and control subjects • Programmed communication during experiences with DMT (dimethyltryptamine) • Studies on the mechanism of action of monoamine oxidase: metabolism of N, N-dimethyltryptamine and N, N-dimethyltryptamine-N-oxide • Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors • Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter • t-Amine oxide rearrangements. N, N-Dimethyltryptamine oxide • Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N, N-dimethyltryptamine in rats treated with a monoamine … • Blood and urine levels of N, N-dimethyltryptamine following administration of psychoactive dosages to human subjects • Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N, N-dimethyltryptamine • Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression • Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 … • N,N-dimethyltryptamine and the pineal gland: Separating fact from myth • The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide • Determination of N, N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca • Adhesion of spheres: the JKR-DMT transition using a Dugdale model • DMT: The spirit molecule: A doctor's revolutionary research into the biology of near-death and mystical experiences • Formation of carboxamides by direct condensation of carboxylic acids and amines in alcohols using a new alcohol-and water-soluble condensing agent: DMT-MM • 513 Mbit/s visible light communications link based on DMT-modulation of a white LED • PAM-DMT for intensity-modulated and direct-detection optical communication systems • Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function • Practical bit loading for DMT • A method to reduce the probability of clipping in DMT-based transceivers
• UW Psilocybin Pharmacokinetics Study • Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors • Psychopharmacology of Psilocybin in Cancer Patients • Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators • Psilocybin Cancer Anxiety Study • Effects of Dimethyltryptamine in Healthy Subjects • Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression • Personality and Drug Use (PDU) • Clinical Study of GH001 in Depression • Safety of GH001 in Healthy Volunteers • Pharmacokinetics of GH001 in Healthy Volunteers • Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans • Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

DNA

• BioEcho Life Sciences

Ecommerce

• Microdelics • Super Funguy • Zamnesia • Spore Wellness • Mycology Now • Magic Mushrooms Dispensary • The Myco Grow • ShroomsDirect • Blue Goba • Psilo Supplements • Champignon Magique • Medicinal Mushroom Dispensary • Microdose Nature • Midwest Grow Kits • Quality Spores • North Spore • Chakra Openings • Cyber-Shrooms • ProviThor • DanceSafe • La Sociedad Psicodélica • MUD\WTR • Azarius • Magic Mushrooms Shop • Shroom Supply • Wholecelium • Avalon Magic Plants • Gorilla Mushroom Kits • Truffle Magic • Elephants • Dutch Growkits • Per Grow • Mushbox • Zativo • Exotic Psyche Pharmaceuticals • Blue Goba • Medicinal Mushroom Dispensary • Microdose Nature • ProviThor • Wholecelium • Irwin Naturals • Microgenix • Dose • Psychedelia • Amazing Shrooms • Blue Buddha • Canada Mushrooms • Psiloscience.ca • Shroomhub.io • Mungus • Shroom World • Room 920 • Psilocybin Lounge • Nupepshrooms • The Magic Kingdom • Magic Mushies • Canada Shrooms Dispensary • 3Amigos Psilocybin • Psychedelic High • Top Shelf Shrooms • Shafaa • Spores-Lab • Zoomers Dispensary • Shroomdose • Fantasy Shrooms • Shrooms Online • Buddhalicious • Organic Shroom Canada • Shrooms Direct • MindLift • MagicMushroomKit.ca

Education

• PRATI • California Institute of Integral Studies • King College London, Institute of Psychiatry, Psychology & Neuroscience • University of Madison-Wisconsin, School of Pharmacy • Maastricht University, Faculty of Psychology and Neuroscience • Johns Hopkins, Center for Psychedelic & Consciousness Research • St. Vincent's Hospital, Melbourne • Psychedelics Asia • Kosmicare • Psilopedia • Adventures Through The Mind • The Psychedelics Analyst • Remedium Project • Psychedelic Psychotherapy Forum • Drug Science • Mindspace • Naropa University • Heffter Research Institute • Psychedelics Today • Micro Mushroom Resource Centre • Gaia • JFK University • CIIS Center for Psychedelic Therapies and Research • School for Advanced Studies in the Social Sciences • Entheogenesis Australis • The Sanctuary Project • Harmonia • DanceSafe • RestPit • Drugs and Me • Check-in Free Mind • NoBox Philipines • Safe Shore - Hof Mivtahim • DÁT2 Psy Help • Keep Smiling • The Psychedelic Society of First Responders and Emergency Workers • Psychedelics and Philosophy • Psychedelic Grad • Evolver • PsychonautWiki • PEERS: Portland Entheogenic Exploration and Research Society • KRIYA Institute (Ketamine Research Institute) • Psychedelic Club • Students for Sensible Drug Policy (SSDP) • Chacruna • PsyCare UK, Welfare and Harm Reduction • Asociación Transpersonal Iberoamericana • ICEERS • Slovak psychedelic society - SAPAS • Awaken • EmmaSofia • Espolea • Alius Research Group • Psychedelic Society Lithuania • Sociedad Psiquedelica Mexico • The Psychedelic Society of the Netherlands • Psychedelics New Zealand • Palestinian Psychedelic Society • Polskie Towarzystwo Psychodeliczne • Lisbon Psychedelic Society • Portuguese Psychedelic Society Portuguese Psychedelic Society • The Psychedelic Society of Edinburgh • The Psychedelic Society of Slovenia • The Psychedelic Society of Madrid • La Sociedad Psicodélica • DanceWize • Herbs and Wonders • Psychedelic Society of Birmingham • The Psychedelic Society • Cambridge Psychedelic Society • Psychedelic Integration UK • The Maudsley Psychedelic Society • UCL Society for the Application of Psychedelics • The Psychedelic Society of Manchester • Solent Psychedelic Community • Psychedelics Courses • Neuly • Sanctus • Psilocybin Foundation • Psychedelic Medicine Association • Psychedelic Institute • Neuma Coaching • Shroomery • Integration Communications • Psychedelic Psychiatry • Psychedelic Warriors • Courage Quests • Imperial College London • Integrative Psychiatry Institute • Berkeley Center for the Science of Psychedelics (BCSP) • REBBLS • Andromeda Entertainment • Charisma on Command • Simba Health • University of Greenwich • Mental Health Professionals Network • MIND Foundation • Portland Psychedelic Society • MAPS Canada • University of Amsterdam, Psychology Research Institute • Zentralinstitut für Seelische Gesundheit • American College of Neuropsychopharmacology • Olson Lab • University of the Sciences • Intercollegiate Psychedelics Network • Psychedelic Pharmacists Association • Atitlantis • Forest Medicine Coaching • Micro-dosing for Healing • Frequency • Bloomers • OVID Health Systems • German Federal Ministry of Education and Research • Beyond Psychedelics • Bmore Psychedelic Society • Catalyst Calgary • Decriminalize Nature • Decriminalize Nature Canada • Edelic Center for Ethnobotanical Services • Erie Vision • The Newly Institute • Psychedelic Social Justice Collective • Healing Advocacy Fund • MAPS • Society for Psychedelic Outreach Reform and Education (SPORE) • Aphrodite Health • People of Color Psychedelic Collective • Ketamine Academy • Global Wellness Institute • Minority Trip Report • Within Center • MagicMushroomKit.ca
• Sr Director, Head of Commercialization and Patient Access • Executive Director

Events

• Meet Delic • The Green Light • Microdose • McKenna Academy • Mind Medicine Australia • 920 Coalition • Psychedelic Psychotherapy Forum • PsyTech (events) • Catharsis on the Mall • Exploring Psychedelics • Horizons • Reform Conference • Women's Visionary Congress • Breaking Convention • Entheogenesis Australis • Safe Shore - Hof Mivtahim • Psychedelic Seminars • PEERS: Portland Entheogenic Exploration and Research Society • DanceWize • Swedish Institute for Psychedelic Science • Psychedelic Society Switzerland • Dandelion • Entheo Generation • REBBLS • Mental Health Professionals Network • CNS Summit • Bloomers • Psychedelic Social Justice Collective

GHB

• Jazz Pharmaceuticals
• Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome • Gamma hydroxybutyric acid (GHB) intoxication • Gamma‐hydroxybutyric acid in the treatment of alcohol dependence: a double‐blind study • Gamma‐hydroxybutyric acid: an emerging recreational drug • Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans • Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers • Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal • Abuse and therapeutic potential of gamma-hydroxybutyric acid • Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence • Gamma-hydroxybutyric acid as hypnotic. Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man. • Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome
• Characterization of the Prosocial and Prosexual Effects of GHB • Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population • Xyrem and Brain Dopamine in Narcolepsy • Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor • Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD) • Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease • Physiological, Behavioral and Subjective Effects of Drugs (GHB) • Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome • Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate • Sodium Oxybate in Schizophrenia With Insomnia • Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes • The Effect of Sodium Oxybate on Sleep Architecture • Evaluation of the Efficacy of Sodium Oxybate (Xyrem) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia • A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics • Sodium Oxybate in Patients With Chronic Fatigue Syndrome. • Sodium Oxybate in Idiopathic Hypersomnia • Enhancing Slow Wave Sleep With Sodium Oxybate • Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome • Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache • Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients • Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response • Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO) • Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia. • SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE) • Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia • Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male • Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • Trial of Xyrem (Sodium Oxybate) for the Treatment of Narcolepsy • Safety and Efficacy Study of Xyrem (Sodium Oxybate) in Subjects With Fibromyalgia. • Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem (Sodium Oxybate) to Treat Fibromyalgia. • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription • Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients • Sodium Oxybate in the Treatment of Binge Eating Disorder • Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction • An Open Label Study of FT218 in Subjects With Narcolepsy • Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV) • Impact of Gamma-OH on Sleep in ICU Patients • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy • Memory Consolidation in Pharmacologically Enhanced Naps • Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder • Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat • Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers • Evaluation of the Efficacy of Sodium Oxybate in the Long-term Maintenance of Abstinence in Alcoholic Patients • Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults • Dose Finding Study of Single Dose GHB11L1 in Healthy Adults • Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults • Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults • Sodium Oxybate Versus Midazolam for Comfort Sedation • Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder. • A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy • Xyrem for Treatment Refractory Insomnia Due to PTSD • A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia